Mason MD - Search Results

1

Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.

Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Clayton A, et al. Among authors: mason md. Cancer Res. 2007 Aug 1;67(15):7458-66. doi: 10.1158/0008-5472.CAN-06-3456. Cancer Res. 2007. PMID: 17671216

2

Apoptosis is a mode of cell death in the polykaryon-forming unit assay.

Manti L, Bowen ID, Mason MD, Court JB. Manti L, et al. Among authors: mason md. Cell Biol Int. 2000;24(7):415-25. doi: 10.1006/cbir.2000.0506. Cell Biol Int. 2000. PMID: 10875889

3

Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer.

Shelley MD, Court JB, Kynaston H, Wilt TJ, Fish RG, Mason M. Shelley MD, et al. Among authors: mason m. Cochrane Database Syst Rev. 2000;2000(4):CD001986. doi: 10.1002/14651858.CD001986. Cochrane Database Syst Rev. 2000. PMID: 11034738 Free PMC article. Review.

4

Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry.

Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, Newman GR, Jasani B. Clayton A, et al. Among authors: mason md. J Immunol Methods. 2001 Jan 1;247(1-2):163-74. doi: 10.1016/s0022-1759(00)00321-5. J Immunol Methods. 2001. PMID: 11150547

5

A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.

Shelley MD, Kynaston H, Court J, Wilt TJ, Coles B, Burgon K, Mason MD. Shelley MD, et al. Among authors: mason md. BJU Int. 2001 Aug;88(3):209-16. doi: 10.1046/j.1464-410x.2001.02306.x. BJU Int. 2001. PMID: 11488731 Review.

6

Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.

Clayton A, Harris CL, Court J, Mason MD, Morgan BP. Clayton A, et al. Among authors: mason md. Eur J Immunol. 2003 Feb;33(2):522-31. doi: 10.1002/immu.200310028. Eur J Immunol. 2003. PMID: 12645951 Free article.

7

Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.

Shelley MD, Court JB, Kynaston H, Wilt TJ, Coles B, Mason M. Shelley MD, et al. Among authors: mason m. Cochrane Database Syst Rev. 2003;(3):CD003231. doi: 10.1002/14651858.CD003231. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2015 Nov 07;(11):CD003231. doi: 10.1002/14651858.CD003231.pub2 PMID: 12917955 Updated. Review.

8

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials.

Shelley MD, Wilt TJ, Court J, Coles B, Kynaston H, Mason MD. Shelley MD, et al. Among authors: mason md. BJU Int. 2004 Mar;93(4):485-90. doi: 10.1111/j.1464-410x.2003.04655.x. BJU Int. 2004. PMID: 15008714 Review.

9

Adhesion and signaling by B cell-derived exosomes: the role of integrins.

Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Clayton A, et al. Among authors: mason md. FASEB J. 2004 Jun;18(9):977-9. doi: 10.1096/fj.03-1094fje. Epub 2004 Apr 1. FASEB J. 2004. PMID: 15059973

10

The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer.

Adams M, Navabi H, Croston D, Coleman S, Tabi Z, Clayton A, Jasani B, Mason MD. Adams M, et al. Among authors: mason md. Vaccine. 2005 Mar 18;23(17-18):2374-8. doi: 10.1016/j.vaccine.2005.01.014. Vaccine. 2005. PMID: 15755631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters